[抑制血管生成的药物——未来的治疗选择]。

Nordisk medicin Pub Date : 1998-11-01

L Perbeck

{"title":"[抑制血管生成的药物——未来的治疗选择]。","authors":"L Perbeck","doi":"","DOIUrl":null,"url":null,"abstract":"In order to grow beyond 2-3 mm in size, a primary tumour or metastasis must induce angiogenesis, the formation of new blood vessels. Tumour capillary content is an independent prognostic factor, usually measured as the mean of three counts in capillary-rich areas of the histological section. Either as single drugs or in combination with other treatment, angiostatic agents probably represent the future of cancer treatment.","PeriodicalId":19261,"journal":{"name":"Nordisk medicin","volume":"113 9","pages":"297-8, 316"},"PeriodicalIF":0.0000,"publicationDate":"1998-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Angiogenesis-inhibiting drugs--a future therapeutic option].\",\"authors\":\"L Perbeck\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In order to grow beyond 2-3 mm in size, a primary tumour or metastasis must induce angiogenesis, the formation of new blood vessels. Tumour capillary content is an independent prognostic factor, usually measured as the mean of three counts in capillary-rich areas of the histological section. Either as single drugs or in combination with other treatment, angiostatic agents probably represent the future of cancer treatment.\",\"PeriodicalId\":19261,\"journal\":{\"name\":\"Nordisk medicin\",\"volume\":\"113 9\",\"pages\":\"297-8, 316\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nordisk medicin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nordisk medicin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

为了生长超过2-3毫米，原发肿瘤或转移瘤必须诱导血管生成，即新血管的形成。肿瘤毛细血管含量是一个独立的预后因素，通常以组织学切片毛细血管丰富区域的三次计数的平均值来测量。无论是单独使用还是与其他药物联合使用，血管抑制剂可能代表着癌症治疗的未来。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Angiogenesis-inhibiting drugs--a future therapeutic option].

In order to grow beyond 2-3 mm in size, a primary tumour or metastasis must induce angiogenesis, the formation of new blood vessels. Tumour capillary content is an independent prognostic factor, usually measured as the mean of three counts in capillary-rich areas of the histological section. Either as single drugs or in combination with other treatment, angiostatic agents probably represent the future of cancer treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nordisk medicin

自引率

0.00%

发文量

期刊最新文献

[Selenium poisoning]. [Influenza vaccination]. [Urinary incontinence in women]. Den dolda svälten, nutrition i utvecklingsländerna - ett angeläget arbete [Sympathetic ophthalmia].